Link to Conference Website Virtual Meeting
Presentation: Optimising Trial Design and Risk-Based Oversight Through Quality by DesignTime: 5:00 p.m. - 5:30 p.m. (GMT)Panelist: Ann Meeker-O'Connell (Vertex Pharmaceuticals)
Presentation: Quality by Design (QbD): Actionable Recommendations and Resources for QbD Adoption from the Clinical Trials Transformation InitiativeTime: 12:50 p.m. - 1:05 p.m. (CET)Presenter: Dagmar Gortz (Janssen)
Presentation: Evolving from the Pandemic: Moving toward a New Vision for Clinical Trials in 2030Time: 2:20 p.m. - 2:40 p.m. (CET)Presenters: Pierre Meulien (Innovative Medicines Initiative) and Pamela Tenaerts (CTTI)